References
- Romero-ArocaPSararolsLAriasLCasaroli-MaranoRPBassaganyasFTopical azithromycin or ofloxacin for endophthalmitis prophylaxis after intravitreal injectionClin Ophthalmol201261595159923109798
- RegeneronBayer and Regeneron report positive top-line results of two Phase 3 studies with VEGF Trap-Eye in wet age-related macular degeneration Available from: http://investor.regeneron.com/releasedetail.cfm?ReleaseID=552099Accessed April 13, 2012
- MoshfeghiAARosenfeldPJFlynnHWJrEndophthalmitis after intravitreal anti-vascular endothelial growth factor antagonists: a six-year experience at a university referral centerRetina201131466266821836400
- McCannelCAMeta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategiesRetina201131465466121330939
- BrechnerFJRosenfeldPJBabishJDCaplanSPharmacotherapy for neovascular age-related macular degeneration: analysis of the 100% 2008 medicare fee-for-service part B claims fileAm J Ophthalmol2011151588789521310390
References
- Sociedad Espanola de Retina y VítreoManejo de las inyecciones intravítreasGuías de Práctica Clínica de la SERV2009 Available from: http://www.serv.esAccessed November 19, 2012
- Royal College of OphthalmologistsGuidelines for intravitreal injections procedure, 2009London, UKRoyal College of Ophthalmologists2009 Available from: http://www.rcophth.ac.ukAccessed November 19, 2012
- BaqueroFMartínez-BeltránJCantónRCriteria of the MENSURA group for the definition of the critical points of sensitivity to antibioticsEnferm Infecc Microbiol Clin19981628592 Spanish9586367